LABCORP HOLDINGS INC. Fair Value Disclosure
| Fair Value Measurements | |||||||||||||||||||||||||||||
| December 31, 2025 | |||||||||||||||||||||||||||||
Consolidated Balance Sheets Classification | Fair Value at December 31, 2025 | Using Fair Value Hierarchy | |||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||
| Noncontrolling interest put | Noncontrolling interest | $ | 16.9 | $ | — | $ | 16.9 | $ | — | ||||||||||||||||||||
| Cross currency swaps | Other liabilities | $ | 274.0 | $ | — | $ | 274.0 | $ | — | ||||||||||||||||||||
| Interest rate swaps | Other liabilities | $ | 52.7 | $ | — | $ | 52.7 | $ | — | ||||||||||||||||||||
| Cash surrender value of life insurance policies | Other assets, net | $ | 99.6 | $ | — | $ | 99.6 | $ | — | ||||||||||||||||||||
| Deferred compensation asset | Other assets, net | $ | 53.1 | $ | — | $ | 53.1 | $ | — | ||||||||||||||||||||
| Deferred compensation liability | Other liabilities | $ | 150.5 | $ | — | $ | 150.5 | $ | — | ||||||||||||||||||||
| Contingent consideration | Accrued expenses and other/Other liabilities | $ | 50.0 | $ | — | $ | — | $ | 50.0 | ||||||||||||||||||||
| Fair Value Measurements | |||||||||||||||||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||||||||
Consolidated Balance Sheets Classification | Fair Value at December 31, 2024 | Using Fair Value Hierarchy | |||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||||
| Noncontrolling interest put | Noncontrolling interest | $ | 14.3 | $ | — | $ | 14.3 | $ | — | ||||||||||||||||||||
| Cross currency swaps | Other liabilities | $ | 142.7 | $ | — | $ | 142.7 | $ | — | ||||||||||||||||||||
| Interest rate swaps | Other liabilities | $ | 76.8 | $ | — | $ | 76.8 | $ | — | ||||||||||||||||||||
| Cash surrender value of life insurance policies | Other assets, net | $ | 102.1 | $ | — | $ | 102.1 | $ | — | ||||||||||||||||||||
| Deferred compensation asset | Other assets, net | $ | 35.7 | $ | — | $ | 35.7 | $ | — | ||||||||||||||||||||
| Deferred compensation liability | Other liabilities | $ | 132.5 | $ | — | $ | 132.5 | $ | — | ||||||||||||||||||||
| Contingent consideration | Accrued expenses and other/Other liabilities | $ | 10.8 | $ | — | $ | — | $ | 10.8 | ||||||||||||||||||||
| Fair Value Measurement of Level 3 Liabilities | Contingent Consideration | |||||||
Balance at December 31, 2023 | $ | 66.1 | ||||||
| Cash payments and adjustments | (55.3) | |||||||
| Balance at December 31, 2024 | 10.8 | |||||||
| Cash payments and adjustments | (4.6) | |||||||
| Additions from business acquisitions | 43.8 | |||||||
| Balance at December 31, 2025 | $ | 50.0 | ||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 26, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 25, 2022 | |
| 2020 | Feb 25, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Feb 28, 2019 | |
| 2017 | Feb 27, 2018 | |
| 2016 | Feb 27, 2017 | |
| 2015 | Feb 29, 2016 | |
About Fair Value Disclosures
Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.
Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.